ARCHIVED - Canadian Institutes of Health Research - Report

• Previous Page
• Table of Contents
•  

This page has been archived.

Section III: Supplementary Information

Financial Highlights

Condensed Statement of Financial Position
As at March 31, 2011 ($ thousands)

	% Change	2011	2010
Assets
Financial Assets	(17.7%)	13,490	16,397
Non-Financial Assets	12.4%	4,781	4,254
Total Assets	(11.5%)	18,271	20,651
Liabilities	(11.4%)	23,218	26,217
Equity of Canada	(11.1%)	(4,947)	(5,566)
Total Liabilities & Equity	(11.5%)	18,271	20,651

Condensed Statement of Operations
For the year ended March 31, 2011 ($ thousands)

	% Change	2011	2010
Grants and awards expenses	4.3%	978,291	938,282
Refund of previous years' grants and awards	(22.7%)	(4,203)	(5,434)
Operating expenses	6.1%	66,108	62,335
Total Expenses	4.5%	1,040,196	995,183
Total Revenues	25.4%	11,462	9,140
Net Cost of Operations	4.3%	1,028,734	986,043

Condensed Statement of Financial Position:

Total assets and total liabilities decreased by $2.4M and $3M, respectively, compared to 2009-10. The decrease in total assets is primarily due to a decrease in the from the Consolidated Revenue Fund. The corresponding decrease in the total liabilities is mainly affected by a decrease in the deferred revenue balance. CIHR recognized $2.3 million of additional revenues in 2010-11 (as compared to 2009-10) due to an increase in funds received from external parties held by CIHR for specified purposes.

Condensed Statement of Operations:

Grants and awards expenses increased by $40M (or 4.3%) in 2010-11 compared to 2009-10. The overall increase in expenses was anticipated due to the additional funding announced in Budget 2010 for CIHR and other funding also received to launch the Canada Excellence Research Chairs Program and to expand existing CIHR initiatives including the Drug Safety and Effectiveness Network and the Centres of Excellence for Commercialization and Research program.

Total operating expenses increased by $3.8M in 2010-11. The majority of this increase is directly related to employee salaries and benefits, as CIHR increased its human resource capacity in order to effectively administer its suite of grants and awards programs, including new programs which were launched in 2010-11 as described above.

Financial Highlights Charts/Graphs

Allocation of CIHR Expenses between Grants and Operating Expenses (1.044B)

View a textual description of the above figure

CIHR allocates 94% of its available budget directly to funding health research, CIHR's primary goals are to fund the improvement of health and the health system through the creation of new knowledge across all areas of health research, to build health research capacity by supporting the training and careers of excellent health researchers, to support and facilitate the commercialization of health research, and to support the creation of new knowledge in strategic priority areas and its translation into improved health and a strengthened health system.

Allocation of CIHR Grants and Awards Expenses ($978.3M)

View a textual description of the above figure

A significant portion of CIHR's grants and awards expenses are incurred to fund programs included under the Health Knowledge program activity to support the best health research and sustain research excellence.

CIHR allocates a large portion of its budget to fund programs under the Health and Health Services Advances program activity. These investments support the best research and researchers through targeted initiatives aligned with CIHR's strategic directions. These strategic investments address emerging health threats and other important health issues of concern to Canadians, including obesity, cancer, vulnerable populations, HIV/AIDS and patient-oriented research. Knowledge translation programs also form a significant portion of Health and Health Services Advances program activity. Knowledge Translation (KT) is a critical and growing part of CIHR's mandate focused on the synthesis, exchange and ethically-sound application of knowledge to accelerate the capture of the benefits of research for Canadians through improved health, more effective services and products and a strengthened health care system. KT expenses grew to more than $49M in 2010-11.

Grants and awards expenses related to the Health Researchers program activity are designed to support the best researchers in health research. Key programs such as the Canada Research Chairs Program and the Canada Graduate Scholarships Program will help Canada attract and retain some of the world's most accomplished and promising minds.

CIHR funds research commercialization programs, such as the Networks of Centres of Excellence Program, to catalyze innovation and help transform today's research discoveries into tomorrow's health solutions.

Financial Statements

All of CIHR's 2010-11 Audited Financial Statements can be found on the CIHR website. Included in this year's audited financial statements:

1. Statement of Management Responsibility Including Internal Control Over Financial Reporting;
2. Financial statements and notes; and
3. Annex: Summary of the Assessment of Effectiveness of the Systems of Internal Control (with Action Plan)

List of Supplementary Information Tables

All electronic supplementary information tables found in the 2010-11 Departmental Performance Report can be found on the Treasury Board of Canada Secretariat's website.

• Sources of Respendable and Non-Respendable Revenue
• Details on Transfer Payment Programs
• Green Procurement
• Internal Audits and Evaluations

WebLinks

• CIHR
• 13 institutes
• Minister of Health
• Natural Sciences and Engineering Research Council
• Social Sciences and Humanities Research Council
• Science & Technology Strategy
• Health Research Roadmap
• Three-year implementation plan and progress report
• Risk Management Framework
• Corporate Risk Profile
• Canada's Economic Action Plan
• Healthy Canadians

---

Section IV: Other Items of Interest

Organizational Contact Information

Canadian Institutes of Health Research
160 Elgin Street, 9th Floor
Ottawa, ON, K1A 0W9
CANADA

General Inquiries: 613-941-2672
Toll Free: 1-888-603-4178
Fax: 613-954-1800

Grants & Awards Information: 613-954-1968
Toll Free: 1-888-603-4178 (press 1)
Email: info@cihr-irsc.gc.ca

---

Footnotes

1. No Sub-Activities related to this Program Activity
2. No Sub-Activities related to this Program Activity
3. Type is defined as follows: Previously committed to—committed to in the first or second fiscal year before the subject year of the report; Ongoing—committed to at least three fiscal years before the subject year of the report; and New—newly committed to in the reporting year of the DPR.
4. Type is defined as follows: Previously committed to—committed to in the first or second fiscal year before the subject year of the report; Ongoing—committed to at least three fiscal years before the subject year of the report; and New—newly committed to in the reporting year of the DPR.
5. Type is defined as follows: Previously committed to—committed to in the first or second fiscal year before the subject year of the report; Ongoing—committed to at least three fiscal years before the subject year of the report; and New—newly committed to in the reporting year of the DPR.
6. Type is defined as follows: Previously committed to—committed to in the first or second fiscal year before the subject year of the report; Ongoing—committed to at least three fiscal years before the subject year of the report; and New—newly committed to in the reporting year of the DPR.
7. This target, originally reported as maintain or increase CIHR total number and average dollar value of grants funded, was changed to ensure consistency and ease in interpreting results.
8. This performance indicator, originally reported as Number, types and share of graduate trainees in Canada compared to international levels, was changed due to the unavailability of data on the share and types of graduate trainees.
9. This target, originally reported as maintain or increase CIHR total number and average dollar value of grants funded, was changed to ensure consistency and ease in interpreting results.
10. This target, originally reported as maintain or increase number of patents, licenses, copyrights, centres; new products or processes; policies influenced or created; influence on health delivery, was changed due to the unavailability of consistent reporting data.The original target will be reconsidered upon the full implementation of CIHR's end-of-grant reporting system.
11. This target, originally reported as maintain or increase CIHR total number and average dollar value of grants funded, was changed to ensure consistency and ease in interpreting results.

• Previous Page
• Table of Contents
•